Revolutionary Eye Chip Restores Vision to the Blind

The quest to restore vision to the blind has taken a significant leap forward with the development of a tiny wireless eye implant at Stanford Medicine. This innovative device, known as the PRIMA chip, has been shown to partially restore vision to individuals with advanced macular degeneration, a condition that affects over 5 million people worldwide. By combining the implant with a pair of advanced smart glasses, patients can regain their ability to read and recognize shapes and patterns.

This breakthrough reflects broader industry trends in the development of neural interfaces and artificial intelligence-powered medical devices. The PRIMA system works by using a small camera attached to the glasses to capture visual information, which is then projected onto the implant via infrared light. The implant, in turn, converts this information into electrical signals that are sent directly to the brain, bypassing damaged photoreceptors.

As noted by Daniel Palanker, PhD, a professor of ophthalmology at Stanford Medicine, “All previous attempts to provide vision with prosthetic devices resulted in basically light sensitivity, not really form vision. We are the first to provide form vision.” This achievement is a testament to the power of interdisciplinary research and collaboration, with contributions from top institutions around the world.

The clinical trial, which involved 38 patients with geographic atrophy due to age-related macular degeneration, demonstrated remarkable results. Within a year of receiving the implant, 27 of the 32 participants who completed the trial were able to read, with some achieving visual sharpness comparable to 20/42 vision. While the current version of the device provides only black-and-white vision, future developments are expected to enable grayscale and potentially even color vision.

The implications of this technology extend far beyond the treatment of macular degeneration. As researchers continue to push the boundaries of what is possible with neural interfaces and artificial intelligence, we can expect to see new innovations that transform the lives of individuals with a range of medical conditions. With the PRIMA chip, we are witnessing the dawn of a new era in vision restoration, one that holds tremendous promise for the millions of people worldwide who are affected by blindness and visual impairment.

Source: https://www.sciencedaily.com/releases/2025/10/251022023118.htm